Dataset from A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00007575
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and efficacy of the study drug known
as ixekizumab in biological disease-modifying anti-rheumatic drugs (bDMARDs)-naive
participants with radiographic axial spondyloarthritis (rad-axSpA).
创建时间：
2025-10-02
